Tags: EU | Britain | GSK

Pharmaceutical Giant GSK Invests in British Sites

Wednesday, 27 July 2016 04:54 AM

LONDON (AP) — GlaxoSmithKline is investing some 275 million pounds ($360 million) into three plants in Britain, sweeping aside concerns about growth following the country's decision to leave the European Union.

The pharmaceutical giant's chief executive Andrew Witty said Tuesday that the Britain's "competitive corporate tax system" and skilled workforce influenced the decision to invest in the manufacturing of new respiratory and large molecule biological medicines.

Witty was among dozens of business leaders who had argued that Britain should remain in the 28-nation single market of some 500 million.

Britain's government describes the decision as a vote of confidence in the country and its workforce.

The investment will go to Durham and Hertfordshire in England and to Montrose in Scotland. The company has nine sites in the U.K., employing 6,000 people.

© Copyright 2019 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

   
1Like our page
2Share
Europe
GlaxoSmithKline is investing some 275 million pounds ($360 million) into three plants in Britain, sweeping aside concerns about growth following the country's decision to leave the European Union.The pharmaceutical giant's chief executive Andrew Witty said Tuesday that the...
EU,Britain,GSK
130
2016-54-27
Wednesday, 27 July 2016 04:54 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved